Lana Pine is the editor of HCPLive Rheumatology. She is an experienced editor and technical writer with a demonstrated history of working in the banking and publishing industries. In her free time, she enjoys cooking, yoga, listening to podcasts, and drawing. She can be reached via email at LPine@mjhlifesciences.com.
Ryan DeMasi, MD: Upadacitinib Monotherapy Compared with Methotrexate in Rheumatoid Arthritis
November 14th 2023Ryan DeMasi, MD, explained despite the patients' shorter disease duration, they exhibited severe symptoms, prompting a more aggressive early intervention approach using treatment with upadacitinib.
Read More
Damini Jawaheer, PhD: Biomarkers may Predict Disease Severity in Pregnant Patients with RA
November 13th 2023Jawaheer and her team used pre-pregnancy data to determine whether there are gene expression biomarkers at the pre-pregnancy baseline that can predict improvement or worsening during pregnancy in patients with rheumatoid arthritis.
Read More
Deeper Anemia Linked to Higher Risk of Bleeding, Stroke in Patients Treated with Warfarin
November 10th 2023Severity-dependent anemia and low hemoglobin levels were significant risk factors for stroke/transient ischemic attack and bleeding in patients with atrial fibrillation treated with warfarin.
Read More
Eltrombopag Demonstrates Safety, Efficacy in Patients with Severe Aplastic Anemia
November 9th 2023Research demonstrates eltrombopag is a safe and effective treatment option for patients with refractory or relapsed severe aplastic anemia, with 70% of patients achieving hematologic response at week 26.
Read More
Low-Flexibility Insurance Plans More Likely to Prescribe Biosimilars
November 7th 2023Results revealed the health plan type highly influenced the likelihood of biosimilar uptake, with low-flexibility insurance plans more likely to have patients who either switched to a biosimilar or were initiated on a biosimilar.
Read More
Stacie Bell, PhD: Lupus Therapeutics and AbbVie to Join Forces for Promising Lupus Treatment Program
November 3rd 2023Stacie Bell, PhD, discusses the partnership between Lupus Therapeutics and AbbVie for the phase 3 clinical program of upadacitinib in patients with SLE, emphasizing the importance of collaboration and their role in accelerating the study process, recruitment, and the potential for meaningful advancements in lupus treatment.
Read More
V Michael Holers, MD: Bridging the Gap Between Research and Patient Impact
November 1st 2023V Michael Holers, MD, discusses the creation of Rheumatology Lab in response to a pressing need within the clinical practice community to provide an easily accessible resource for physicians to guide patients to valuable information.
Read More